Physician profile

Michael B Deyoung

Cardiovascular Disease · Mount Clemens, MI

NPI 1487861043

$69,211.82

in general payments reported to CMS, 2019-2025

41 companies · $16K in 2025

The $16K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Travel and Lodging$8,455.18
Food and Beverage$8,082.05
Consulting Fee$6,250.00
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$3,250.00
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program$2,250.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $38,113.43 2019-2025 Diamondback Coronary, Xience Sierra, Coroflow
Cardiovascular Systems INC. $12,155.76 2020-2023 Diamondback Coronary
Medtronic, INC. $9,010.25 2022-2025 Mo.Ma Ultra, Symplicity G3, Onyx Frontier
Boston Scientific Corporation $1,957.54 2019-2025 Eluvia, Watchman Access System, Emerge Push
Abiomed $1,846.97 2020-2025 Impella
Novartis Pharmaceuticals Corporation $694.11 2019-2024
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $656.83 2020-2025 Lifevest
Kestra Medical Technology Services, INC. $498.05 2023-2024 Assure Wcd
Inari Medical, INC. $456.36 2023-2025 Ct Thrombectomy System Kit, Flowtriever Catheter, S
E.R. Squibb & Sons, L.L.C. $390.49 2019-2025 Camzyos, Eliquis
Janssen Pharmaceuticals, INC $367.06 2019-2024 Xarelto
Shockwave Medical, INC $341.94 2022-2025 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Penumbra, INC. $283.63 2024-2025 Indigo System
Pfizer INC. $255.16 2019-2024
Philips North America LLC $223.96 2022-2025 Azurion 7 M20, (5044) Mcot
Show all 41 companies
CompanyGeneral paymentsYearsTop products
Astellas Pharma US INC $218.75 2019-2021
Amgen INC. $201.43 2019-2024 Repatha
Kiniksa Pharmaceuticals, LTD. $198.90 2021-2023 Arcalyst
Astrazeneca Pharmaceuticals LP $180.85 2019-2023 Farxiga, Brilinta
Cardiva Medical, INC. $152.17 2023 Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f
Bracco Diagnostics INC. $135.78 2019
Recor Medical INC $126.00 2025 Paradise Ultrasound Renal Denervation System
Boehringer Ingelheim Pharmaceuticals, INC. $118.11 2022-2023 Jardiance
Terumo Medical Corporation $104.92 2021-2023 Angio-Seal
Edwards Lifesciences Corporation $77.66 2023-2024 Sapien 3 Ultra Resilia
Regeneron Healthcare Solutions, INC. $50.93 2019-2022
Kiniksa Pharmaceuticals International, Plc $48.28 2024 Arcalyst
Cook Medical LLC $46.77 2024 Zilver Ptx
Medtronic Vascular, INC. $44.45 2019-2020
Bard Peripheral Vascular, INC. $31.41 2023 Crosser Iq
Irhythm Technologies, INC. $31.21 2023 Zio Xt Patch
Zoll Circulation INC $30.00 2022
Actelion Pharmaceuticals US, INC. $28.36 2024 Uptravi, Opsumit
Ekos Corporation $26.17 2019
Novo Nordisk INC $23.43 2024 Wegovy
Daiichi Sankyo INC. $18.59 2023 Injectafer
Angiodynamics, INC. $16.05 2024 Auryon Laser System 100-120 Vac
Esperion Therapeutics, INC. $13.25 2020
Osprey Medical INC $13.00 2019
Gilead Sciences, INC. $12.71 2019
Teleflex LLC $11.10 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Michael B Deyoung

$69,211.82

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbott Laboratories
Context
The $16K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/249174/michael-b-deyoung

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.